Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Springfield, Missouri


Purpose:

The objective of this study was to assess bioequivalence of a potential generic 600 mb oxcarbazepine tablet formulation compared with Novartis Pharmaceutical's 600 mg oxcarbazepine tablet, Trileptal, following a single 600 mg dose, administered with food.


Criteria:

Inclusion Criteria: - No clinically significant abnormal finding on the physical examination, medical history, or clinical laboratory results at screening. Exclusion Criteria: - Positive test for HIV, Hepatitis B, or Hepatitis C. - Treatment with any known enzyme altering drugs. - History of allergic or adverse response to oxcarbazepine or any other comparable or similar product.


NCT ID:

NCT00618046


Primary Contact:

Principal Investigator
Dennis Morrison, D.O.
Bio-Kinetic Clinical Applications, Inc.


Backup Contact:

N/A


Location Contact:

Springfield, Missouri
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 17, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.